# OnCo record paper-qi-orimiracle-gastrointestinal-cancer-med-2023 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-qi-orimiracle-gastrointestinal-cancer-med-2023/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-qi-orimiracle-gastrointestinal-cancer-med-2023" ;
  schema:name "Monitoring of gastrointestinal carcinoma via molecular residual disease with circulating tumor DNA using a tumor-informed assay"@en ;
  schema:description "A personalised blood test from OrigiMed found leftover cancer before and after surgery for stomach and bowel cancer."@en ;
  schema:url <https://onco.cc/key-papers/paper-qi-orimiracle-gastrointestinal-cancer-med-2023/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://doi.org/10.1002/cam4.6286>, <https://pubmed.ncbi.nlm.nih.gov/37602656/> ;
  schema:sameAs <https://doi.org/10.1002/cam4.6286> ;
  schema:datePublished "2023"^^xsd:gYear ;
  schema:author "Qi Z, Li Y, Wang Z, et al." ;
  onco:cancers <https://onco.cc/cancers/gastric/>, <https://onco.cc/cancers/colorectal/> ;
  onco:sections <https://onco.cc/fronts/diagnostics/> ;
  onco:technologies <https://onco.cc/technologies/mrd-testing/> ;
  onco:drugs <https://onco.cc/drugs/orimiracle-s/> ;
  onco:companies <https://onco.cc/companies/origimed/> ;
  onco:terms <https://onco.cc/terms/mrd/>, <https://onco.cc/terms/ctdna/>, <https://onco.cc/terms/tumour-informed-assay/> ;
  onco:journals <https://onco.cc/journals/cancer-medicine/> .